Michael Busse

Exposure to TiO2 nanoparticles increases Staphylococcus aureus infection of HeLa cells

Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance

The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

A Randomized Double-blind Placebo-controlled Phase 2 Dose-ranging Study of OnabotulinumtoxinA in Men with Benign Prostatic Hyperplasia

International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease

Parkinson's disease

Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain

Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis

Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial

Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects

Low Level of Brain Dopamine D₂ Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Parkinson's disease

The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses

Effects of toxic doses of methamphetamine (METH) on dopamine D1 receptors in the mouse brain

Toxic effects of silver nanoparticles in mammals – does a risk of neurotoxicity exist?

Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations

Effect of chronic restraint stress on dendritic spines and excrescences of hippocampal CA3 pyramidal neurons—a quantitative study

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

Responsiveness and Clinical Utility of the Geriatric Self‐Efficacy Index for Urinary Incontinence

EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

Non-motor features of Parkinson disease

Therapeutic options for nocturnal problems in Parkinson’s disease and atypical parkinsonian disorders

The antimicrobial activity of nanoparticles: present situation and prospects for the future

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis

Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women

Diagnosis and Treatment of Parkinson Disease

Rotator Cuff Repair

Prevalence and characteristics of asymptomatic tears of the rotator cuff

Modeling the effects of nanoparticles on neuronal cells: From ionic channels to network dynamics

Evaluation of painful sensory symptoms in restless legs syndrome: Experience from two clinical trials

Single doses of methamphetamine cause changes in the density of dendritic spines in the prefrontal cortex of gerbils (Meriones unguiculatus)

Normalwerte der Schulterkraft in Abhängigkeit von Alter und Geschlecht - Vergleich zum Constant-, UCLA-, ASES-Score und SF-36 Fragebogen

Estimating the modulatory effects of nanoparticles on neuronal circuits using computational upscaling

The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms

Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease

Efficacy and augmentation during 6months of double-blind pramipexole for restless legs syndrome

Long‐term safety and sustained efficacy of extended‐release pramipexole in early and advanced Parkinson's disease

Extended-release pramipexole in advanced Parkinson disease